Skip to content
Review Open access

Gut Microbiota, Oxidative Stress, and Extracellular Vesicles: Molecular Crosstalk in Inflammation and Disease and Therapeutic Interventions

2026 · Biocell (Mendoza) · pp. 1-10 · 0 citations · 293 references

TL;DR

The gut microbiota, oxidative stress, and extracellular vesicles (EVs) form an interdependent triad essential for gastrointestinal homeostasis and systemic health and integrated multi-omics and standardized EV profiling are needed for precision medicine approaches.

Abstract

: The gut microbiota, oxidative stress, and extracellular vesicles (EVs) form an interdependent triad essential for gastrointestinal homeostasis and systemic health. This narrative review summarizes the molecular crosstalk among these components in inflammation and disease. Literature was retrieved from PubMed and Scopus using relevant keywords and reference screening. Gut microbes regulate redox balance through metabolites such as short-chain fatty acids and modulation of host reactive oxygen species (ROS) production via mitochondrial pathways and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase. Dysbiosis has been associated with excessive ROS generation, impaired antioxidant defenses, and activation of redox-sensitive signaling pathways, including nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κ B), NOD-like receptor pyrin domain containing 3 (NLRP3) inflammasome, and mitogen-activated protein kinase (MAPK), contributing to inflammatory and metabolic diseases. EVs act as mediators of host-microbe communication by transferring bioactive cargo that may influence oxidative stress, immune responses, and epithelial integrity. Host-derived EVs, shaped by redox status, may further contribute to systemic inflammation associated with chronic diseases. Therapeutic strategies include microbiota modulation, antioxidants, nuclear factor erythroid 2-related factor 2 (Nrf2) activators, NADPH oxidase inhibitors, and EV-based interventions. Integrated multi-omics and standardized EV profiling are needed for precision medicine approaches.

Read PDF

Similar papers

Review Open access Aug 2026

Emerging microbiome–mitochondria crosstalk in host defense and infectious diseases: mechanistic insights into NLRP3 inflammasome activation and mtDNA-mediated immunomodulation

These investigations emphasize the emerging mechanistic significance of microbiota-induced modulation of mitochondrial function in host defense mechanisms, thereby illuminating potential therapeutic approaches that focus on microbial composition, mitochondrial dynamics, and inflammasome signaling to alleviate infectiou...

Xinxing Lu, Wenbin Sun, Daowei Zhang et al. · 1 citation
Review Open access Aug 2026

Gut microbiota-derived metabolites as context-dependent modulators of Nrf2 signaling in inflammation-driven carcinogenesis

It is proposed that microbial metabolites represent a context-dependent mechanism for modulating Nrf2 activity in inflammation-associated cancers, with important implications for translational and precision medicine approaches.

My-Lan Pianka, Xuelei Zhang, C. Stein-Thoeringer · 0 citations
Review Open access Aug 2026

Endoplasmic Reticulum Stress-Driven Inflammatory Mediators in Metabolic Disorders: From Molecular Mechanisms to Targeted Therapies.

This review delineates how the canonical UPR sensors transduce metabolic stress into pro-inflammatory signaling cascades and discusses the organ-specific consequences of ERS in the liver, pancreas, adipose tissue, vascular endothelium, and hypothalamus, highlighting how this stress sustains a self-reinforcing cycle of...

B. Wen, Xiaojin Wu, Kaiying Zhang et al. · 0 citations
Review Open access Aug 2026

Bacterial Extracellular Vesicles as Regulators of the Gut Microbiome–Circadian Axis in Inflammatory and Metabolic Diseases

Understanding the BEV–gut microbiome–circadian axis provides new mechanistic insights into host–microbe communication and highlights BEVs as promising postbiotic candidates for restoring immune–metabolic homeostasis and developing next-generation microbiome-targeted therapeutics.

Hyejin Choi, S. Oh, Young-Hun Kim · 0 citations
Review Open access Jul 2026

Gut microbiota and gut-kidney axis in kidney diseases: therapeutic potential and perspectives of natural products

Gut microbiota exert core regulatory effects on systemic metabolic homeostasis and immune balance under physiological and pathological conditions. Marked gut dysbiosis occurs during the progression of chronic kidney disease (CKD), characterized by abnormal enrichment of opportunistic pathogens and depletion of benefici...

Qian-Wei Wang, Jiahe Zhang, Ruiyan Chen et al. · 0 citations
Review Open access Sep 2026

Microbiota-mitochondria axis in neurodegenerative disorders and retinal dysfunction: mechanisms and emerging therapeutic opportunities

Current evidence represents the microbiota–mitochondria axis as a one of the promising mechanistic and therapeutic targets for neurodegenerative and ocular diseases, however, most therapeutic evidence discussed in this review is derived from preclinical studies, with relatively limited clinical validation.

Puneet K. Samaiya, Akshat Agrawal, Shrija Kesharwani et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.